If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
387.50    -8.50 (-2.15%)
Bid:
387.00
Ask:
393.00
Spread: 6.00 (1.55%)
Market Cap: £1.76b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Half Yearly Report

21 Aug 2014 07:00

RNS Number : 6756P
HgCapital Trust PLC
21 August 2014
 



HgCapital Trust plc

Interim Results for the six months ended 30 June 2014

 

 

London, 21 August 2014: HgCapital Trust plc ("the Trust"), which provides investors with a listed vehicle to invest in all private equity deals managed by HgCapital, today announces its interim results for the six months ended 30 June 2014.

 

 

Summary performance

 

Pro-forma 31 July(1)2014

30 June2014

 31 December 2013

% Totalreturn(2)

NAV per share

£12.20

£12.18

£11.80

+5.8%

Share price

£10.20

£10.07

£10.10

+2.5%

FTSE All-Share Index

+1.6%

June 2014Movement

Net Asset Value

£455.5m

£454.6m

£440.6m

+£14.0m

 

(1) Including estimated impact of Voyage transaction due to complete in September

(2) Assuming reinvestment of all dividends

 

Financial Highlights

 

· NAV per share +5.8% on a total return basis to £12.18.

· Share price +2.5% on a total return basis to £10.07.

· The Board have approved a special dividend of 19 pence per share to be paid on 26 September 2014, reflecting a one-off dividend receipt from Visma.

· Strong revenue growth of 10% and EBITDA growth of 9% across the top 20 primary mid-cap buyout investments over the last twelve months to 30 June 2014.

· An EV to EBITDA valuation multiple of 12.4x and debt to EBITDA ratio of 4.6x as at 30 June 2014 for the top 20 primary mid-cap buyout investments.

· Estimated liquid resources (including all post June transactions) available for deployment are £91 million (20% of pro-forma NAV) with outstanding commitments of £225 million (49% of pro-forma NAV).

· +13.4% p.a. 10-year compound annual growth rate of the share price vs. +8.6% p.a. from the FTSE All-Share Index, both calculated on a total return basis to 30 June 2014.

 

Investment Activity

 

· £72 million deployed on behalf of the Trust over 2014 to date, principally in five buyout investments (Visma, Zenith, Ullink, Relay Software and Sequel Business Solutions).

· £70 million of cash returned to the Trust over 2014 to date including four buyout exits (Visma, Schleich, Manx Telecom, and Americana); an estimated further £8.4 million to be returned post completion of the Voyage sale.

 

Manager Outlook

 

· We have made a number of interesting acquisitions over the last year, with a clear plan on how to create value within these businesses.

 

· Whilst we remain cautious on the market environment for investing we see opportunities to make selective new and bolt-on acquisitions, at reasonable prices over the next twelve months.

 

· Looking further out, we feel more confident about our portfolio than we did twelve months ago and we are working hard to further improve the operational performance of our companies, the effects of this are yet to be fully reflected in our valuations. This will be further enhanced by a sustained recovery in the economic environment.

 

· We believe that the above, together with consistently realising investments for good value, will deliver steady NAV progression over the next couple of years and therefore we remain confident that we will continue to reward our investors with long-term superior returns.

 

 

Roger Mountford, Chairman of the Trust, commented:

 

"Strong trading and profitable realisations over the first half of 2014 have driven solid NAV growth with further deployment into new and bolt-on investments building a store of value for future returns. The Board is pleased to announce a special dividend payment which reflects the one-off receipt of a dividend from Visma".

 

- Ends -

 

The Trust's 2014 Interim Report and a webcast from the Manager to accompany the results are available to view at: http://www.hgcapitaltrust.com/.

 

For further details:

HgCapital

Stephen Bough

(CFO, HgCapital)

+44 (0)20 7089 7888

Roger Mountford

Maitland

(Chairman, HgCapital Trust plc)

+44 (0) 77996 626 01

Tom Eckersley

Peter Ogden

 

+44 (0)20 7379 5151

+44 (0)20 7379 5151

 

 

 

About HgCapital Trust plc

 

HgCapital Trust plc is an investment trust whose shares are listed on the London Stock Exchange. The Trust gives investors exposure, through a liquid vehicle, to a portfolio of high-growth private companies, managed by HgCapital, an experienced and well-resourced private equity firm with a long-term track record of delivering superior risk-adjusted returns for its investors.

 

For further details, see www.hgcapitaltrust.com and www.hgcapital.com

Neither the contents of HgCapital's website, HgCapital Trust's website nor the contents of any website accessible from hyperlinks on the websites (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PGUGWRUPCGMU
Date   Source Headline
18th Sep 20237:00 amRNSHalf-year Report and Dividend Declaration
5th Sep 20238:00 amRNSHg agrees to sale of Commify to ECI Partners
17th Aug 20238:00 amRNSHg agrees to partial sale of TeamSystem
4th Aug 20237:15 amRNSEdison issues review on HG Capital Trust (HGT)
20th Jul 20237:00 amRNSHg announces investment in Nomadia
19th Jun 20237:00 amRNSAzets Group secures investment from PAI to join Hg
18th May 20239:00 amRNSHg announces investment in GTreasury
17th May 20235:21 pmRNSResult of AGM
15th May 20237:00 amRNSQ1 2023 Report to 31 March 2023
12th May 20234:53 pmRNSBlock listing Interim Review
4th Apr 202310:04 amRNSDirector/PDMR Shareholding
3rd Apr 20233:51 pmRNSUpdate on HGT's Commitment to Hg's Saturn 3 Fund
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 202310:35 amRNSDirector/PDMR Shareholding
28th Mar 202312:24 pmRNSDirector/PDMR Shareholding
16th Mar 20232:14 pmRNSHgCapital Trust results summary with Doceo
15th Mar 202310:55 amRNSDirector/PDMR Shareholding
13th Mar 202310:51 amRNSUpdate on Silicon Valley Bank
13th Mar 20237:00 amRNSAnnual Results & Notice of Annual General Meeting
13th Mar 20237:00 amRNSAnnual Financial Report
31st Jan 20234:50 pmRNSBlock listing Interim Review
13th Dec 20227:00 amRNSHg agrees to sale of Transporeon
16th Nov 20227:00 amRNSEdison issues update on HgCapital Trust (HGT)
14th Nov 20227:00 amRNS3rd Quarter Results
1st Nov 202210:10 amRNSTotal Voting Rights
14th Oct 20227:00 amRNSTransaction in Own Shares
5th Oct 20227:00 amRNSIdeagen and ProcessMAP to Combine
4th Oct 20228:25 amRNSTrustQuay Secures Hg Investment
4th Oct 20227:00 amRNSTrustQuay Secures Hg Investment
13th Sep 20227:46 amRNSEdison issues update on HgCapital Trust (HGT)
12th Sep 20227:00 amRNSHgCapital Trust Interim Results 2022
12th Sep 20227:00 amRNSHalf-year Report
2nd Aug 20223:38 pmRNSHolding(s) in Company
20th Jul 20225:50 pmRNSHolding(s) in Company
14th Jul 20221:00 pmRNSHg announces a partial sale of Intelerad
7th Jul 20224:40 pmRNSReplacement: Director/PDMR Shareholding
6th Jul 20227:30 amRNSHg announces further investment in team.blue
5th Jul 20221:43 pmRNSDirector/PDMR Shareholding
4th Jul 20225:18 pmRNSDirector/PDMR Shareholding
28th Jun 20224:00 pmRNSNorstella announces merger agreement with Citeline
24th Jun 20227:00 amRNSHGT Board note agreement on acquisition of Ideagen
14th Jun 20227:00 amRNSHg agrees sale of MEDIFOX DAN to ResMed for US$1bn
9th Jun 20223:56 pmRNSInvestment in TigerRisk Partners
8th Jun 20227:00 amRNSHg further invests in The Access Group
17th May 20226:00 pmRNSHg agrees the sale of itm8 to Axcel
17th May 20227:00 amRNSEdison issues review on HgCapital Trust (HGT)
13th May 20224:54 pmRNSBlock listing Interim Review
10th May 20225:34 pmRNSResult of AGM
9th May 20227:00 amRNS1st Quarter Results
3rd May 20223:23 pmRNSAGM Update - Withdrawal of AGM Resolution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.